Valuation (22%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 28.08 | N/A |
| PEG Ratio (TTM) | 6.85 | N/A |
| P/S Ratio (TTM) | 2.66 | N/A |
| P/B Ratio (TTM) | 3.99 | N/A |
| P/FCF Ratio (TTM) | 24.10 | N/A |
| Price to 5YR AVG Earnings Ratio | N/A | N/A |
| Price to 5YR AVG FCF Ratio | N/A | N/A |
Profitability (40%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 6.40% | N/A |
| ROE (TTM) | 15.39% | N/A |
| Net Profit Margin (TTM) | 9.47% | N/A |
| ROIC 5YR AVG | N/A | N/A |
Growth (40%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 6.65% | 11.92% | N/A |
| Revenue | -0.25% | 6.04% | N/A |
| Net Income | 6.80% | 11.86% | N/A |
| Cash Flow | 14.68% | -3.22% | N/A |
Health (49%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.92 | N/A |
| Quick Ratio (TTM) | 1.25 | N/A |
| D/E Ratio (TTM) | 0.59 | N/A |
| Interest Coverage (TTM) | 5.68 | N/A |
| Piotroski F-Score | 7 | N/A |
| Altman Z-Score | 3.36 | N/A |
| LTL to 5YR AVG FCF | N/A | N/A |
| Shares Outstanding Growth 5YR AVG | N/A | N/A |